The differing effects of antipodes of racemic pharmaceuticals have prompted the use of enantiomerically pure materials as therapeutic agents and have exacerbated the long-standing need for methodologies for enantiomerically pure synthesis. Since enzymes demonstrate remarkable selectivity in their transformations, they are key components in industrially feasible methods for synthesis of fine chemicals and pharmaceuticals. The pyruvate aldolases can be used as catalysts for stereocontrolled carbon-carbon bond formation in the synthesis of pharmaceutical intermediates. However, the rigid substrate specificity of this enzyme limits its utility in organic synthesis. We propose here a unique approach towards understanding the structural basis of enzyme catalysis and molecular recognition that combines synthetic organic chemistry, molecular biology, mechanistic enzymology, and X-ray crystallography. In toto, we aim to provide a new group of synthetically useful catalysts, develop methodologies for directed evolution, and extract detailed enzyme mechanistic information that will be interpreted in terms of enzyme structure. Specifically, we will: (1) Expand and/or shift the substrate specificity range of 2-keto-3-deoxy-6-phosphogluconafe (KDPG) aldolase to use both novel electrophiles and nucleophiles; (2) Demonstrate the synthetic utility of novel biocatalysts through concise environmentally benign syntheses of pharmaceutical intermediates; (3) Evaluate the catalytic behavior of mutated enzymes with a range of electrophilic and nucleophilic substrates; and (4) Determine the molecular structure of the mutated proteins through X-ray diffraction techniques. Together, these studies will significantly advance the goal of rational catalyst/biocatalyst design/redesign and enhance the synthetic utility of the pyruvate aldolases.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM061596-04
Application #
6837146
Study Section
Special Emphasis Panel (ZRG1-SSS-B (01))
Program Officer
Ikeda, Richard A
Project Start
2002-01-01
Project End
2006-12-31
Budget Start
2005-01-01
Budget End
2006-12-31
Support Year
4
Fiscal Year
2005
Total Cost
$308,483
Indirect Cost
Name
Duke University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Cheriyan, Manoj; Toone, Eric J; Fierke, Carol A (2012) Improving upon nature: active site remodeling produces highly efficient aldolase activity toward hydrophobic electrophilic substrates. Biochemistry 51:1658-68
Cheriyan, Manoj; Walters, Matthew J; Kang, Brian D et al. (2011) Directed evolution of a pyruvate aldolase to recognize a long chain acyl substrate. Bioorg Med Chem 19:6447-53
Walters, Matthew J; Srikannathasan, Velupillai; McEwan, Andrew R et al. (2008) Characterization and crystal structure of Escherichia coli KDPGal aldolase. Bioorg Med Chem 16:710-20
Cheriyan, Manoj; Toone, Eric J; Fierke, Carol A (2007) Mutagenesis of the phosphate-binding pocket of KDPG aldolase enhances selectivity for hydrophobic substrates. Protein Sci 16:2368-77
Snyder, Phillip W; Johannes, Matthew S; Vogen, Briana N et al. (2007) Biocatalytic microcontact printing. J Org Chem 72:7459-61
Fullerton, Stephen W B; Griffiths, Jennifer S; Merkel, Alexandra B et al. (2006) Mechanism of the Class I KDPG aldolase. Bioorg Med Chem 14:3002-10
Griffiths, Jennifer S; Cheriyan, Manoj; Corbell, Jayme B et al. (2004) A bacterial selection for the directed evolution of pyruvate aldolases. Bioorg Med Chem 12:4067-74